ロード中...
Extranuclear Coactivator Signaling Confers Insensitivity to Tamoxifen
PURPOSE: Tamoxifen is one of many standard therapeutic option currently available for estrogen receptor-alpha (ER)-positive breast cancer patients. Emerging data have suggested that levels of ER coregulatory proteins play a significant role in acquiring resistance to anti-estrogen action. It has bee...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2756964/ https://ncbi.nlm.nih.gov/pubmed/19470742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-2347 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|